- Home
- SVRA vs KREF Comparison
SVRA vs KREF Comparison
Compare SVRA & KREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- KREF
- Stock Information
- Founded
- SVRA 2007
- KREF 2014
- Country
- SVRA United States
- KREF United States
- Employees
- SVRA N/A
- KREF N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- KREF Real Estate Investment Trusts
- Sector
- SVRA Health Care
- KREF Real Estate
- Exchange
- SVRA Nasdaq
- KREF Nasdaq
- Market Cap
- SVRA 528.3M
- KREF 623.1M
- IPO Year
- SVRA N/A
- KREF 2017
- Fundamental
- Price
- SVRA $2.21
- KREF $9.00
- Analyst Decision
- SVRA Buy
- KREF Buy
- Analyst Count
- SVRA 5
- KREF 8
- Target Price
- SVRA $5.60
- KREF $12.22
- AVG Volume (30 Days)
- SVRA 1.2M
- KREF 786.2K
- Earning Date
- SVRA 08-11-2025
- KREF 07-21-2025
- Dividend Yield
- SVRA N/A
- KREF 11.15%
- EPS Growth
- SVRA N/A
- KREF N/A
- EPS
- SVRA N/A
- KREF 0.16
- Revenue
- SVRA N/A
- KREF $97,478,000.00
- Revenue This Year
- SVRA N/A
- KREF $31.59
- Revenue Next Year
- SVRA N/A
- KREF $7.29
- P/E Ratio
- SVRA N/A
- KREF $55.34
- Revenue Growth
- SVRA N/A
- KREF 93.07
- 52 Week Low
- SVRA $1.89
- KREF $8.28
- 52 Week High
- SVRA $5.11
- KREF $12.95
- Technical
- Relative Strength Index (RSI)
- SVRA 41.30
- KREF 45.98
- Support Level
- SVRA $1.98
- KREF $8.63
- Resistance Level
- SVRA $2.29
- KREF $9.10
- Average True Range (ATR)
- SVRA 0.14
- KREF 0.21
- MACD
- SVRA 0.02
- KREF -0.02
- Stochastic Oscillator
- SVRA 42.19
- KREF 43.53
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About KREF KKR Real Estate Finance Trust Inc.
KKR Real Estate Finance Trust Inc is a real estate finance company that focuses on originating and acquiring senior mortgage loans secured by CRE assets. The investment is to originate or acquire senior mortgage loans collateralized by institutional-quality CRE assets that are owned and operated by experienced and well-capitalized sponsors and located in liquid markets with underlying fundamentals. KKR manages investments across multiple asset classes, including private equity, real estates, energy, infrastructure, credit, and hedge funds. The company's investment objective is capital preservation and generating attractive risk-adjusted returns for its stockholders over the long term, through dividends.